Status:
COMPLETED
COVID-19 And Lingering Symptoms In Primary Care Patients
Lead Sponsor:
Katarina Hedin
Collaborating Sponsors:
Research Unit for General Practice in Aalborg
Utrecht University
Conditions:
Covid19
Symptoms and Signs
Eligibility:
All Genders
18+ years
Brief Summary
The ongoing corona virus disease 2019 (COVID-19) is a viral acute respiratory tract infection caused by server acute respiratory syndrom coronavirus typ 2 (SARS-CoV-2). The signs and symptom of SARS-C...
Eligibility Criteria
Inclusion
- Confirmed SARS-CoV-2 infection, either by polymeras chain reaction (PCR), or by antigen testing (if authorized/recommended/used by national/local governments)
- Symptoms consistent with mild to moderate COVID-19
- Maximum of 2 weeks since positive SARS-CoV-2 test
- Aged 18 years and older
- Patient able and willing to comply with monthly phone calls.
Exclusion
- Hospitalisation due to COVID-19
Key Trial Info
Start Date :
December 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04813731
Start Date
December 12 2020
End Date
June 30 2022
Last Update
September 4 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp
Antwerp, Belgium
2
the Academic Centre for General Practice (ACHG), Department of Public Health and Primary Care, KU Leuven
Leuven, Belgium
3
Center for General Practice at Aalborg University
Aalborg, Denmark
4
Département de Santé Publique, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Nice, France
Nice, France